Related Experiment Video
Updated: Jul 10, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
[Childhood leukemia: a genetic disease!]
Daniel Sinnett1, Nina N'Diaye, Pascal St-Onge
1Service d'Hématologie-Oncologie, Centre de Cancérologie Charles-Bruneau, Centre de Recherche, Hôpital Sainte-Justine, Québec, Canada. daniel.sinnett@umontreal.ca
Genetic variations are linked to childhood leukemia risk. Combinations of gene variants appear more predictive of risk than individual ones, highlighting the complexity of pediatric cancer susceptibility.
Area of Science:
- Pediatric Oncology
- Cancer Genetics
- Molecular Epidemiology
Context:
- Childhood cancer is a leading cause of death in children, with limited understanding of its causes.
- Pediatric oncogenetics research, particularly for acute lymphoblastic leukemia (ALL), has focused on genetic factors.
- Genetic variations are recognized contributors to cancer susceptibility, yet their role in childhood leukemia requires further exploration.
Purpose:
- To investigate the association between candidate genes in key biological pathways and childhood leukemogenesis.
- To evaluate the role of genetic polymorphisms in susceptibility to childhood leukemia.
- To determine if combined genotypes offer better prediction of leukemia risk than individual genotypes.
Summary:
- Association studies were conducted on candidate genes involved in cellular growth, DNA repair, metabolism, apoptosis, oxidative stress, and cell cycle.
- Results indicate that genetic variants are associated with childhood leukemia.
- The combination of genotypes was found to be more predictive of leukemia risk than individual genotypes.
Impact:
- Suggests that genetic variations contribute to the development of childhood leukemia.
- Emphasizes the need for investigating multiple genes and metabolic pathways to understand the complex etiology of childhood leukemia.
- Highlights the importance of considering inter-individual variability in genetic susceptibility to pediatric cancers.
Related Concept Videos
Cancer Prevention
Some...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
